Advanced Non-Melanoma Skin Cancer: PD-1–Targeted Therapy

Experts reflect on potential benefit with PD-1–targeted therapy in the settings of basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (cSCC).

For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/

• Categoria